VitaDAO is a decentralized membership collective funding early-stage longevity research. Its mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner. VitaDAO will own the intellectual property assets that result from the projects it supports, and members of VitaDAO govern the structure and its decision-making processes. Members can join VitaDAO by purchasing VITA tokens or earning them through contributions of work or intellectual property.
We believe the future of biopharma is transparent, collaborative, and open source.
The Challenge
Value creation in biopharma centers heavily around intellectual property assets and patents as core drivers for funding and innovation. Yet intellectual property ownership as a business model has barely evolved in the past century. Current biopharma business models carry severe limitations and R&D inefficiencies that cost those, who should be the core stakeholders: patients and researchers.
The Solution
VitaDAO is an open cooperative that anyone can join, with the goal to acquire, support, and finance new therapeutics and research data in the longevity space. The VitaDAO collective co-develops IP with researchers, growing a portfolio of assets represented as IP-NFTs and other tokens.
